Cesca Therapeutics Expands CAR-TXpress™ Intellectual Property Portfolio with Filing of New Patent Covering Cell Activation & Transduction
19 mars 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics to Announce Financial Results for the Transition Period From July 1, 2017 to December 31, 2017 on March 22
15 mars 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca’s Device Subsidiary, ThermoGenesis, Expands into CAR-T Related Contract Development and Manufacturing (CDMO) Services
14 mars 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics Inc. to Present at BIO-Europe Spring® 2018
06 mars 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) today announced that Joe Balagot, senior vice president of corporate development, will...
Cesca Therapeutics Inc. to Present at the 8th Spring Meeting of the International Society for BioProcess Technology (ISBiotech)
28 févr. 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics Inc. Announces Commercial Launch of AXP® II System for Advanced Cord Blood Processing
26 févr. 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics Inc. to Present at the BIO CEO & Investor Conference on Monday, February 12, 2018
05 févr. 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018
02 janv. 2018 07h00 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics Inc. to Participate in the LD Micro 10th Annual Main Event on Thursday, December 7, 2017
30 nov. 2017 07h30 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock
29 nov. 2017 09h07 HE
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...